India's drug regulator has declared 53 medicines, including calcium and vitamin D3 supplements, diabetes pills and high blood pressure medicines, as having failed quality tests. These include medicines from several reputed companies. The Central Drugs Standard Control Organization (CDSCO) has found more than 50 medicines to be of poor quality. These include calcium and vitamin D3 supplements, diabetes pills and high blood pressure medicines. These medicines were found to be substandard in the random sampling done every month.
These medicines failed the quality test
CDSCO has added the names of 53 medicines to its new Not of Standard Quality (NSQ) alert list. State drug officials do random sampling every month and NSQ alerts are issued on that basis. The medicines that have failed the quality test include many famous medicines like Vitamin C and D3 tablets Shelcal, Vitamin B Complex and Vitamin C Softgel, Antacid Pan-D, Paracetamol Tablet IP 500 MG, diabetes medicine Glimepiride, high blood pressure medicine Telmisartan. These medicines are manufactured by companies like Hetero Drugs, Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics and Pharmaceuticals Limited, Meg Lifesciences, Pure and Cure Healthcare.
From Covid vaccine to TB-dengue… Delhi's Gokulpuri is ready for every trial, sero survey continues
PressNews24 provides latest news, bollywood news, breaking news hollywood, top tech news, business standard news, indian economy news, world economy news, travel news, mumbai news, latest news mumbai loksabha election 2024, video viral news, delhi news, Only at PressNews24.in
People who consume paracetamol and Pan D should be careful
Metronidazole, a drug used to treat stomach infections, also failed the quality test. It is manufactured by PSU Hindustan Antibiotics Limited (HAL). Hypertension drug Telmisartan also failed the test. Shelcal, distributed by Torrent Pharmaceuticals and manufactured by Uttarakhand-based Pure & Cure Healthcare, also failed the test. Besides, a Kolkata-based drug testing laboratory has declared Alkem Health Science's antibiotics Clavam 625 and Pan D as fake. The same laboratory found Hyderabad-based Hetero's Cepodem XP 50 dry suspension, which is given to children for severe bacterial infections, to be of substandard quality. Karnataka Antibiotics and Pharmaceuticals Limited's Paracetamol tablets were also declared to have failed the quality test.
Two lists of medicines that failed quality tests released
The Drug Controller of India has released two lists of medicines that failed the quality test. One list contains 48 popular medicines, while the other list contains 5 more medicines, along with the responses of the drug companies that failed the test. However, the companies in their responses have refused to take responsibility for the medicines and said that these are fake. The column of the drug manufacturers' response states that the actual manufacturer (as per the label claim) has stated that this batch of the product has not been manufactured by them and it is a fake drug. It is being said that the product is fake, however, it is being investigated.
156 medicines were banned
In August, the CDSCO banned over 156 fixed-dose drug combinations from the Indian market, saying they posed a risk to people. These drugs included fever, painkillers and allergy pills.
